Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression.
about
Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic nicheInhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 proteinProinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cellsRAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesisEpigenetics in myeloid derived suppressor cells: a sheathed sword towards cancerGenetics and biology of pancreatic ductal adenocarcinomaImmunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS SitesFrom tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumorsInfiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in miceSpotlights on immunological effects of reactive nitrogen species: When inflammation says nitric oxideNeutrophils and Granulocytic MDSC: The Janus God of Cancer ImmunotherapyThe Crosstalk between Myeloid Derived Suppressor Cells and Immune Cells: To Establish Immune Tolerance in TransplantationMyeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacyTargeted immune therapy of ovarian cancerIL-17 mediated inflammation promotes tumor growth and progression in the skinIdentification of myeloid derived suppressor cells in dogs with naturally occurring cancerLaquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunityPhosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell functionSuppression of proteoglycan-induced autoimmune arthritis by myeloid-derived suppressor cells generated in vitro from murine bone marrowSHIP-deficient dendritic cells, unlike wild type dendritic cells, suppress T cell proliferation via a nitric oxide-independent mechanismSubsets of myeloid-derived suppressor cells in tumor-bearing miceLeukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapyFormation and role of exosomes in cancer.Longitudinal confocal microscopy imaging of solid tumor destruction following adoptive T cell transfer.Single-walled carbon nanotubes-mediated in vivo and in vitro delivery of siRNA into antigen-presenting cells.Myelodysplastic syndromes: the role of the immune system in pathogenesis.Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor.Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma modelGene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease.Cancer-induced expansion and activation of CD11b+ Gr-1+ cells predispose mice to adenoviral-triggered anaphylactoid-type reactionsModified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model.Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer.Rapid release of cytoplasmic IL-15 from tumor-associated macrophages is an initial and critical event in IL-12-initiated tumor regression.Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism.Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patients.T cells contribute to tumor progression by favoring pro-tumoral properties of intra-tumoral myeloid cells in a mouse model for spontaneous melanoma.Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells.Type I interferons inhibit the generation of tumor-associated macrophages.Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells.IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and myeloid-derived suppressor cells
P2860
Q24606366-ABA39D7A-2977-4C8F-B475-276BCAAFD826Q24641894-3782200A-A57A-455C-AB0A-9FD619DC701BQ24658240-70BA26CF-24FB-45DF-A35D-1D1CB74F7242Q24658378-8594EF72-3848-4F44-A843-01B7421C50CAQ26741623-A88A2550-931C-4CCE-BB9D-314F5E40F170Q26765438-8AE386B4-C265-4A88-9FC4-057E789B1545Q26798402-52FEB74C-0D1A-4101-8198-608EF91D1C10Q26865532-F1B942C4-03AC-4FAF-9F2C-E3F7FF651ED9Q27307172-953F541B-03C0-4366-B7B0-6D81EB7968A3Q27694770-7FD5C984-339C-4267-AB4C-A9A8DA766242Q28069360-9BBFDEB9-A85F-4098-9B4B-CA1C7E191B9AQ28077757-D67D8527-B4A9-4700-A1C0-E51F1F112D6FQ28082461-0036E4FF-D343-4B47-8C7C-B0437B41F603Q28082828-5ACA5662-DE44-45C8-9F42-B94B9219AFADQ28480915-49B7EBA9-D7BB-49F7-81EA-641E4C3164BBQ28481476-C22765CC-E40B-4022-B64B-BA6A3C8DE86FQ28481922-C08CDA9D-C9C1-4A94-952F-84BD901F8E93Q28510096-F2774D7F-256F-4CED-8ABA-CBE63C038C55Q28544715-7F2B2D8C-AF4E-4564-9CF2-6E1E0FF36364Q28742855-147E0FDA-8B11-4E2F-9D49-C30A1D802126Q29614297-BD5D2CAE-99F8-411B-9778-E40395E29A30Q29618033-5BB96012-7881-4E5F-8602-EF375A913801Q30303067-B8B44F93-03E5-40C5-AB70-074F117FE4A1Q30565493-B1015F86-EACA-417B-8FDE-6E85AA074305Q33250007-1CA277D4-403E-416E-B592-95665A22E961Q33351527-4C808531-22B0-4F8B-B855-2266827C7833Q33474008-BF50CD1E-6920-49C0-81E2-2A589CDB5648Q33527427-5DCF759D-0B93-49D0-A62B-06A0E793E953Q33559278-FF067307-A035-4CA9-AB17-742488B43E7EQ33713324-761945FD-590E-49C2-97E8-C39B29437129Q33723063-6C9E743F-D2AC-46E8-B839-45F2630A5EA9Q33733198-F046E213-085F-4FFF-AF0A-5D3D19B7CD52Q33738154-B5477A0A-216D-4BD6-8A34-5F2E2C32693DQ33763653-6362D4ED-E868-49C9-9F9E-F9E7232A696CQ33889439-1E3CB533-526F-4FB1-AC00-8E90A0BF558DQ33919802-6C55EDF8-1AE1-4B9F-B515-83C0B6DF4D17Q33919954-1799396A-BB69-4FEE-BBE5-F75B5B96FA8BQ33943369-FA0EFE32-642B-4C67-9746-189292A73732Q34072679-55F9BF4C-BD37-4A1A-ADF9-51ABB5D1C611Q34095907-F4F9FE66-2D08-4FF4-AB66-A8802F77BC6A
P2860
Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Myeloid suppressor cells in ca ...... hanisms of immune suppression.
@ast
Myeloid suppressor cells in ca ...... hanisms of immune suppression.
@en
type
label
Myeloid suppressor cells in ca ...... hanisms of immune suppression.
@ast
Myeloid suppressor cells in ca ...... hanisms of immune suppression.
@en
prefLabel
Myeloid suppressor cells in ca ...... hanisms of immune suppression.
@ast
Myeloid suppressor cells in ca ...... hanisms of immune suppression.
@en
P2093
P1476
Myeloid suppressor cells in ca ...... hanisms of immune suppression.
@en
P2093
Ivan Borrello
Paolo Serafini
Vincenzo Bronte
P356
10.1016/J.SEMCANCER.2005.07.005
P577
2005-09-15T00:00:00Z